Axios @axios
18 of the largest global drug companies will have a combined $538 billion in cash on hand by the end of 2022 and billions more in debt-financing power. https://t.co/X6FNc3qhHO — PolitiTweet.org
Created
Wed Dec 15 12:16:23 +0000 2021
Likes
33
Retweets
15
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
18 of the largest global drug companies will have a combined $538 billion in cash on hand by the end of 2022 and billions more in debt-financing power. https://t.co/X6FNc3qhHO — PolitiTweet.org